We want to know what samples you’re looking for…and why.

A specimen suited for early-stage R&D differs from one needed in a companion diagnostic submission to the FDA. Our smarter approach delivers fit-for-purpose biospecimens, aligned with your scientific and compliance objectives.

We want to know what samples you’re looking for… and why.

A specimen suited for early-stage R&D differs from one needed in a companion diagnostic submission to the FDA. Our smarter approach delivers fit-for-purpose biospecimens, aligned with your scientific and compliance objectives.

We Are

+

=

Solving your biospecimen needs by bringing QUALITY, RELIABILTY and SERVICE to Pharma and Diagnostic Research

We are

Science

Science

From sequencing to flow, FISH to IHC, catalog to custom, we get it, because we live it.

scale

Scale

Wholly-owned labs, clinical sites, and a trial network that spans five continents.

selection

Selection

All specimen types, all volumes, with quality and compliance first
—across the globe.

Smarter Samples Start with Precision.

VIABLE CELLS

Peripheral blood mononuclear cells, bone marrow mononuclear cells, apheresis products, and custom-derived, isolated cell subsets.

PROSPECTIVE COLLECTIONS

Custom-developed, IRB-approved cross-sectional and longitudinal specimen collections, across all clinical indications.

TISSUES

FFPE, Fresh, and Frozen tissues with detailed annotation, including standard of care and novel biomarker data (e.g. PDL1 expression across multiple clones, NTRK fusion status).

MEDICAL SURPLUS SAMPLES

Remnant, residual specimens previously tested and ethically collected.

BIOFLUIDS

Blood, plasma, serum, CSF, and urine — all volumes, all matrices and collection tube types.

25 Million

Biospecimens Managed

6 Labs

Wholly owned, CAP, CLIA, ISO & FDA-Registered

55+

Countries with real-time sample processing

500+

Dx & Rx trials conducted

3+ Million

PBMC, DNA & RNA isolations

We've Built a Stellar Leadership Team

Rob Fannon
General Manager

Rob brings two decades of hands on experience in the biospecimen and biomarker lab services industry at Roche, Cancer Genetics, and BioServe.

Jim Boushell
Vice President

Jim pioneered the field of biospecimen procurement, co-founding ProMedDx over 20 years ago.

Jim Sperzel
Vice President

Jim leveraged his experience at Abbott Diagnostics to co-found ProMedDx in 1988.

Cullen Taylor, MD
Medical Director

As a full-time pathologist and founder of the uniquely consultative biospecimens company Glas, Dr. Taylor embodies our vision for smarter samples.

Brian Hart
Senior Director

Brian’s direct and broad biospecimen experience at Asterand Ventana/Roche and HealthTell sets him apart in the industry.

Deborah Phippard, PhD
SVP, Research

Led biomarker and drug development programs for Rx and Dx companies, as well as the National Institutes of Health.

Angelina Bisconte
Director of Translational Biology & Biomarker Development

Authority in utilizing human primary biological tissue and cells in research and drug discovery. Strategist in multi-parametric single-cell flow cytometry and analysis of flow cytometry data.

Jay Lezcano
SVP, Business Development

Has led Precision for Medicine lab and biospecimen business development strategic initiatives since inception of the company.

Darren Davis, PhD
SVP

Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology.

Joseph Bower, PhD, MBA
SVP, Lab Services

Experienced senior leader spanning the academic, pharmaceutical, and CRO industries.

Get Priority Access Today

Help us better address your specimen requirements, so we can further supplement our inventory with the samples you need.

Complete this brief form and get priority access. We’ll send you this handy portable charger as a thank you.

World-Class Quality Standards & Certifications

Get Priority Access